Xenetic Biosciences, Inc. - Common Stock, $0.001 par value per share (XBIO)

Q: What does CUSIP 984015602 represent in this 13F holders report?

CUSIP 984015602 is the security identifier for XBIO - Xenetic Biosciences, Inc. - Common Stock, $0.001 par value per share used to aggregate holder disclosures.

Q: How many institutions held XBIO - Xenetic Biosciences, Inc. - Common Stock, $0.001 par value per share in Q2 2023?

9 institutional investors reported XBIO - Xenetic Biosciences, Inc. - Common Stock, $0.001 par value per share for Q2 2023. Use the holders table for investor-level position and value details.

CUSIP: 984015602

Q2 2023 13F Holders as of 30 Jun 2023

Type / Class: Equity / Common Stock, $0.001 par value per share
Shares outstanding: 2,290,667
Total 13F shares: 36,642
Share change: +36,642
Total reported value: $120,375
Price per share: $3.28
Number of holders: 9
Value change: +$120,375
Number of buys: 9

Security key

984015602

Report period

Q2 2023

Institutions

Top holders

XBIO full security history Newer quarter: Q3 2023 Xenetic Biosciences, Inc. SEC filings Xenetic Biosciences, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 984015602

Newer quarter: Q3 2023

Recent filing periods:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of XBIO - Xenetic Biosciences, Inc. - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
RENAISSANCE TECHNOLOGIES LLC	13F	Company	— class O/S missing	99,507	$40,000	—	31 Mar 2023	13F
VANGUARD GROUP INC	13F	Company	— class O/S missing	96,982	$39,375	—	31 Mar 2023	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	— class O/S missing	91,545	$37,716	—	31 Mar 2023	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	— class O/S missing	77,819	$32,061	—	31 Mar 2023	13F
HRT FINANCIAL LP	13F	Company	— class O/S missing	37,473	$15,000	—	31 Mar 2023	13F
STATE STREET CORP	13F	Company	— class O/S missing	34,668	$14,283	—	31 Mar 2023	13F
JTC Employer Solutions Trustee Ltd	13F	Company	— class O/S missing	26,991	$11,000	—	31 Mar 2023	13F
TWO SIGMA SECURITIES, LLC	13F	Company	— class O/S missing	20,224	$8,211	—	31 Mar 2023	13F
Steward Partners Investment Advisory, LLC	13F	Company	— class O/S missing	19,000	$7,714	—	31 Mar 2023	13F
NORTHERN TRUST CORP	13F	Company	— class O/S missing	17,760	$7,211	—	31 Mar 2023	13F
CITADEL ADVISORS LLC	13F	Company	— class O/S missing	16,366	$6,743	—	31 Mar 2023	13F
Ergoteles LLC	13F	Company	— class O/S missing	12,773	$5,262	—	31 Mar 2023	13F
Tower Research Capital LLC (TRC)	13F	Company	— class O/S missing	11,354	$5,000	—	31 Mar 2023	13F
GREAT VALLEY ADVISOR GROUP, INC.	13F	Company	— class O/S missing	10,600	$4,304	—	31 Mar 2023	13F
MORGAN STANLEY	13F	Company	— class O/S missing	2,952	$1,199	—	31 Mar 2023	13F
NewSquare Capital LLC	13F	Company	— class O/S missing	260	$106	—	31 Mar 2023	13F
FMR LLC	13F	Company	— class O/S missing	217	$89	—	31 Mar 2023	13F
UBS Group AG	13F	Company	— class O/S missing	977	$76	—	31 Mar 2023	13F
WELLS FARGO & COMPANY/MN	13F	Company	— class O/S missing	105	$43	—	31 Mar 2023	13F

Institutional Holders of Xenetic Biosciences, Inc. - Common Stock, $0.001 par value per share (XBIO) as of Q2 2023

As of 30 Jun 2023, Xenetic Biosciences, Inc. - Common Stock, $0.001 par value per share (XBIO) was held by 9 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 36,642 shares. The largest 9 holders included RENAISSANCE TECHNOLOGIES LLC, Royal Bank of Canada, JTC Employer Solutions Trustee Ltd, Steward Partners Investment Advisory, LLC, Tower Research Capital LLC (TRC), MORGAN STANLEY, NewSquare Capital LLC, WELLS FARGO & COMPANY/MN, and FMR LLC. This page lists 9 institutional shareholders reporting positions in this security for the Q2 2023 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2023 vs Q4 2025 Across Filers

Q4 2025 holders

Q2 2023 holders

Holder diff

-2

Investor	Q4 2025 Shares	Q2 2023 Shares	Share Diff	Share Chg %	Q4 2025 Value $	Q2 2023 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.